GT Biopharma, Inc. (OTCQB: GTBP) Soars 69% After Preclinical Testing of its Tri-Specific Killer Engagers (TriKEs) Were Found to Eliminate HIV-Infected Cells
GT Biopharma, Inc. (OTCQB: GTBP) is engaged as an immune-oncology biotechnology company, which is focused on developing innovative treatments based ...
